<PAGE>
MGI MGI PHARMA, INC.
LOGO
Suite 300E, Opus Center
9900 Bren Road East
Minnetonka, Minnesota 55343
------------------
AMENDMENT TO PROXY STATEMENT
FOR
ANNUAL MEETING OF SHAREHOLDERS
MAY 12, 1998
Due to a delay in the receipt of certain information, the Proxy Statement
for the Annual Meeting of Shareholders of MGI PHARMA, INC. ("MGI"), which was
mailed to shareholders of MGI on April 7, 1998, omitted the following item from
the list of shareholders appearing in "Security Ownership of Certain Beneficial
Owners and Management" on pages 17 and 18.
AMOUNT AND NATURE
NAME OF BENEFICIAL OWNER OF BENEFICIAL OWNERSHIP PERCENT OF CLASS
- ------------------------ ----------------------- ----------------
Avenir Corporation ** 762,680 5.4%
1725 K Street, NW, Suite 410
Washington, D.C. 20006
** Disclosure is made in reliance upon a statement on Schedule 13G, dated as
of December 18, 1997, filed with the Securities and Exchange Commission.
BY ORDER OF THE BOARD OF DIRECTORS
/s/ Lori-jean Gille
Lori-jean Gille
Secretary
April 16, 1998
